Sun Pharmaceutical Industries Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is PRASUGREL HYDROCHLORIDE, with a corresponding US DMF Number 27104.
Remarkably, this DMF maintains an Active status since its submission on May 10, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 11, 2013, and payment made on May 02, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II